In Vivo Fluticasone Absorption in Surgical Patients
The Laryngoscope · 2024
DOI: 10.1002/lary.31050 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Saangyoung E Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Sinusitis, Rhinitis. Die Arbeit nennt 13 Literaturangaben. Gefördert von: NCATS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Intranasal corticosteroids (INCS) are a treatment mainstay of chronic rhinosinusitis and allergic rhinitis. Current computational models demonstrate that >90% of INCS drug deposition occurs on the head of the inferior turbinate and nasal valve, rather than the actual sinuses. These models do not consider mucociliary clearance which propels mucus posteriorly, nor do they consider the absorption of the drug. The purpose of this study is to better understand the exact anatomical location where INCS are absorbed.
Methods
Patients with chronic rhinosinusitis and allergic rhinitis taking fluticasone pre‐operatively who were scheduled for functional endoscopic sinus surgery and inferior turbinate reduction, respectively, were recruited. Intra‐operative tissue samples were obtained from predetermined locations within the sinonasal cavity. Mass spectrometry was then used to quantify the amount of absorption in each specific anatomic location to determine the largest amount of absorption.
Results
Eighteen patients were included in our study. The greatest fluticasone absorption levels across the sinonasal anatomy were at the anterior inferior turbinate (5.7 ngl/mL), ethmoid sinus, (4.4 ng/mL), posterior inferior turbinate (3.7 ng/mL), maxillary sinus (1.3 ng/mL), and the sphenoethmoidal recess (0.72 ng/mL) respectively. Absorption was significantly higher in revision surgery compared to surgically naïve patients.
Conclusions
Computation fluid dynamic models of the nasal passage are useful models to help predict intranasal particle flow. However, these models do not incorporate or consider the important mucociliary clearance system, leading to absorption of fluticasone throughout the sinonasal cavity far beyond that predicted by these models. Level of Evidence 2 Laryngoscope , 134:1551–1555, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
ORCID-Profile: Saangyoung E Lee, Elizabeth Ritter, Adam J Kimple
Förderung
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Lee, S. E., Ritter, E., Nguyen, T. T., Onuorah, P. C., Ebert, C. S., Senior, B. A., Thorp, B. D., & Kimple, A. J. (2024). In Vivo Fluticasone Absorption in Surgical Patients. The Laryngoscope. https://doi.org/10.1002/lary.31050
Vancouver
Lee SE, Ritter E, Nguyen TT, Onuorah PC, Ebert CS, Senior BA, et al. In Vivo Fluticasone Absorption in Surgical Patients. The Laryngoscope. 2024. doi:10.1002/lary.31050
BibTeX
@article{Lee2024,
author = {Lee, Saangyoung E and Ritter, Elizabeth and Nguyen, Tuong T and Onuorah, Princess C and Ebert, Charles S and Senior, Brent A and Thorp, Brian D and Kimple, Adam J},
title = {In Vivo Fluticasone Absorption in Surgical Patients},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31050}
}
EUVIMED